Recent Works

• Gordon G. Liu on China's healthcare reforms, drug innovation & future pandemic response2024-08-23
• Wu ZT et al., “Hospital admission risks and ambient fine particulate matter exposure in Beijing, China,” Atmospheric Environment, 2022, 288:1.2022-11-01
• Zhang, T., Liang, Z., Lin, T. et al. Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension. BMC Med 20, 407 (2022)2022-10-25
• Gordon G. Liu, Jing Wu, et al, Policy Updates on Access to and Affordability of Innovative Medicines in China, VALUE HEALTH REG ISSUES. 2022; 30:59–62022-07-01
• Chengxiang Tang, Jiayi Jiang, Yuanyuan Gu & Gordon Liu (2022) Amending the Law for Licensing Medical Practitioners of China in 2021: A Commentary, Health Systems & Reform, 8:12022-04-13
• Samantha A Vortherms & Gordon G Liu, 2022. "Hukou as benefits: Demand for hukou and wages in China," Urban Studies, Urban Studies Journal Limited, vol. 59(15), pages 3167-3183, November.2022-04-08
• Xuxi Zhang, Lizi Lin, Xinying Sun, Xiaoyan Lei, Gordon G Liu, Hein Raat, Yi Zeng, Development and Validation of the Disability Index Among Older Adults, The Journals of Gerontology: Series A, 2022;, glac0592022-03-10
• Gordon G. Liu, Haijing Guan, et al., Rural population’s preferences matter: a value set for the EQ‑5D‑3L health states for China's rural popula, Health and Quality of Life Outcomes, 20222022-01-29
• Gordon Liu, Zhiyong Huang, Qian Xin, "Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients", Evid Based Complement Alternat Med. 2021; 2021: 9972386.2021-10-28
• Liu GG, et al. “Will high-speed railway influence the healthcare seeking behaviour of patients? Quasi-experimental evidence from China, Health Policy and Planning, Volume 36, Issue 10, December 2021, Pages 1633–1643, https://doi.org/10.1093/heapol/czab0182021-05-31
• Peng Nie，Gordon G Liu，et al, "Income-related health inequality among Chinese adults during the COVID-19 pandemic: evidence based on an online survey", Int J Equity Health . 2021 Apr 26;20(1):106. doi: 10.1186/s12939-021-01448-9.2021-04-26
• Butt T...Liu G. et al., "The Influence Of Cost-Effectiveness Evidence And Other Factors On China's National Reimbursement Drug Listing Decis2020-12-25
• Chen C., Liu G., et al.,“Association between household fuel use and sleep quality in the oldest-old: Evidence from a propensity-score m2020-09-17
• Shi W., Liu G., et al., "Association between provincial income levels and drug prices in China over the period 2010-2017", Social Science an2020-08-05
• Zhou Q., Qin X., Liu G., "Relative Economic Status and Mental Health among Chinese Adults: Evidence from the China Health and Retirement L2020-07-01
• Yao Y., Liu G., “Disease and disparity in China: a view from stroke and MI disease,” International J for Equity in Health, June 11, 2020.2020-06-13
• Yao Y., Liu G., et al., "Job training and organizational performance: Analyses from medical institutions in China2020-04-30
• Wang M., Liu G., et al., “The role of mediation committee in solving medical disputes in China,” BMC Health Services Research, 2020, 20, 222020-03-18
• Myerson R., Liu G., "The impact of government income transfers on tobacco and alcohol use: Evidence from China2020-01-30
• Liu G. et al., "Does Ownership Matter for Medical System Performance? Evidence from a Natural Experiment in Suqian, China," Inquiry, 2020,2020-01-29